Session Sponsor - Thermo Fisher (Platinum sponsor) and vendor pitch
Anat Tambur - 8:30 - 9:10
In search of permissible and unacceptable HLA-DQ mismatching
Borae Park - 9:10 - 9:40
Efforts Towards Harmonization of Histocompatibility Results and Optimization of Tests for Deceased Donor Transplant in Korea: Past, Present, and Future
Narelle Watson - 9:40 - 10:00
Impact of the new Kidney matching and allocation algorithm on transplant rates of Highly sensitised patients in Australia
Session Sponsor - ParagonCare (Silver + sponsor) and vendor pitch
Prof Jill Hollenbach - 10:30 - 11:10
Ask Me Anything: HLA Insights Through Donor Registry Surveys
Prof Katsushi Tokunaga - 11:10 - 11:40
Genome diversity and disease associations
Dr Silvana Gaudieri - 11:40 - 12:00
Human genetic diversity: an immunological advantage but a technical challenge
David Lowe
Defining HLA-specific antibody epitopes using adsorption-elution Techniques
Prof Rob Liwski - 13:30 - 14:10
From Halifax to AXE, Developing Cutting Edge Protocols for HLA Antibody Detection
Prof Michaela Lucas -14:10 - 14:40
Tissue resident immunity in solid organ transplantation
Lloyd D'Orsogna -14:50 - 15:00
C3d-binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post-CDC era?
Wai Lim - 14:50 - 15:00
HLA, Alleles and Antibodies: A Clinician's Perspective
Dr Fredrick Mobegi - 15:30 - 15:40
Harnessing the power of third-generation sequencing and cloud computing to enhance immunogenetics.
Opportunity, anecdote, or pseudo-sci-tech?
David Lowe - 16:00 - 16:10
Defining the crucial residues for HLA antibody binding using site-directed mutagenesis
Melinda Jasper - 16:50 -17:00
Development of a method to sequence homologous chromosomes from a single cell